drugset / Trial / NCT03512223

Intravenous and Perineural Dexamethasone for Brachial Plexus Block in Hand Surgery

NCT03512223 ↗

Phase 0 Completed 108 enrolled Ohio State University
RandomizedParallel-groupSingle-blindPrevention

Summary

This study aims to evaluate the if the administration of dexamethasone both around the nerve and in the vein (perineural and intravenous (IV)) will prolong the duration of pain relief from ropivacaine when compared with ropivacaine local block alone or when administered along with IV dexamethasone in patients undergoing hand surgery.

Timeline

Start
2018-10-23
Primary completion
2024-10-20
Completion
2024-10-20

Outcome

Met primary endpoint

paper sensory block duration was significantly prolonged by 4.5 h (95% CI, 1.3 to 7.7; P = 0.006) in the intravenous dexamethasone group PMID 40036049 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 5 mg Intravenous
Subject Dexamethasone Small molecule 10 mg Intravenous

Indications

No indication recorded.